Lilly CEO Blames Slower Innovation on Immigration, Tax Laws

The U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly & Co. Chief Executive Officer John Lechleiter told a technology conference today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.